https://clinicaltrials.gov/ct2/show/NCT02778399?type=Intr&cond=Endometriosis&lupd_s=05%2F27%2F2019&lupd_d=14
Condition : Endometriosis
Interventions : Drug: Placebo; Drug: OBE2109
Sponsor : ObsEva SA
Active, not recruiting
A Study to Assess the Efficacy and Safety of OBE2109 in Subjects With Endometriosis
NCT02778399
Thu, 19 May 2016 12:00:00 EDT
Last Update Posted: 06/10/19 10:02AM